Who Owns Pacira BioSciences, Inc. (PCRX)?Hedge Fund & Institutional Holders
Institutional Holders
50
as of Q4 2025
Total Institutional Value
$InfinityT
% of Float Held
7.1636193600467375e+295%
QoQ Change in Holders
+9 / -2
Price History
PCRX — Biggest New Institutional Buyers This Quarter
| Fund | Action | Shares Added | Value Added |
|---|---|---|---|
| Impax Asset Management Group plc | New Position | +750K | +$19.4B |
| CITADEL ADVISORS LLC | Increased | +749K | +$19.2B |
| GAGNON SECURITIES LLC | New Position | +501K | +$13.0B |
| Hillsdale Investment Management Inc. | New Position | +308K | +$7.0B |
| PRINCIPAL FINANCIAL GROUP INC | New Position | +261K | +$6.8B |
| Gagnon Advisors, LLC | New Position | +261K | +$6.8B |
| Assenagon Asset Management S.A. | Increased | +203K | +$5.3B |
| TWO SIGMA INVESTMENTS, LP | Increased | +219K | +$5.0B |
| RICE HALL JAMES & ASSOCIATES, LLC | New Position | +181K | +$4.7B |
| FIRST TRUST ADVISORS LP | Increased | +179K | +$3.7B |
| Hennion & Walsh Asset Management, Inc. | New Position | +138K | +$3.6B |
| BANK OF AMERICA CORP /DE/ | Increased | +25K | +$3.0B |
| Doma Perpetual Capital Management LLC | Increased | +76K | +$2.3B |
| Simplify Asset Management Inc. | New Position | +86K | +$2.2B |
| XTX Topco Ltd | New Position | +83K | +$2.0B |
PCRX — Institutions Reducing or Closing Positions
| Fund | Action | Shares Sold | Value Sold |
|---|---|---|---|
| BALYASNY ASSET MANAGEMENT L.P. | Decreased | -939K | -$24.6B |
| JACOBS LEVY EQUITY MANAGEMENT, INC | Decreased | -482K | -$12.8B |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | Closed Position | -410K | -$10.6B |
| UBS Group AG | Decreased | -296K | -$7.6B |
| RENAISSANCE TECHNOLOGIES LLC | Decreased | -254K | -$7.1B |
| Invesco Ltd. | Decreased | -273K | -$7.0B |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | Decreased | -28K | -$6.8B |
| DIMENSIONAL FUND ADVISORS LP | Decreased | -213K | -$6.8B |
| J. Goldman & Co LP | Decreased | -232K | -$5.9B |
| ROYAL BANK OF CANADA | Decreased | -183K | -$5.6B |
| JPMORGAN CHASE & CO | Decreased | -148K | -$5.2B |
| Pacer Advisors, Inc. | Decreased | -11K | -$5.2B |
| NORTHERN TRUST CORP | Decreased | -46K | -$3.8B |
| Connor, Clark & Lunn Investment Management Ltd. | Closed Position | -136K | -$3.5B |
| NATIXIS | Decreased | -90K | -$3.2B |
Top Institutional Holders(Q4 2025)
PCRX Institutional Ownership History
| Quarter | Holders | Total Value | Change |
|---|---|---|---|
| Q4 2025 | 262 | $649.3B | +85 |
| Q3 2025 | 177 | $699.2B | -24 |
| Q2 2025 | 201 | $664.6B | -32 |
| Q1 2025 | 233 | $1.0T | +15 |
| Q4 2024 | 218 | $5.2T | +26 |
| Q3 2024 | 192 | $12.0T | -29 |
| Q2 2024 | 221 | $31.9T | +11 |
| Q1 2024 | 210 | $954.8T | — |
Similar Stocks by Institutional Ownership
As of Q4 2025, 50 institutional investors hold PCRX (Pacira BioSciences, Inc.). The largest holder is Doma Perpetual Capital Management LLC with $71.9B in shares. This quarter, 9 institutions opened new positions and 2 closed their positions.
Frequently Asked Questions
How many hedge funds own PCRX?
As of Q4 2025, 50 institutional investors report holding PCRX (Pacira BioSciences, Inc.) in their 13F filings.
Who is the largest institutional holder of PCRX?
The largest institutional holder of PCRX is Doma Perpetual Capital Management LLC with $71.9B in shares.
Is institutional ownership of PCRX increasing or decreasing?
This quarter, 9 institutions opened new positions in PCRX and 2 closed their positions.